Sera Prognostics
SERA • NASDAQ
Sera Prognostics is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Zhenya Lindgardt, with a market cap of $72.4M.
CEOZhenya Lindgardt
Next Earnings
Upcoming earnings announcement for Sera Prognostics
Date
Wednesday, May 6, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.17
Revenue Estimate
$118.0K
Earnings History
Past 12 earnings reports for Sera Prognostics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 18, 2026 | Q4 2025 | -$0.16Est: -$0.18 | +11.1% | $10.0KEst: $16.0K | -37.5% | — |
| Nov 13, 2025 | Q3 2025 | -$0.16Est: -$0.20 | +20.0% | $16.0KEst: $88.0K | -81.8% |  10-Q |
| Aug 6, 2025 | Q2 2025 | -$0.16Est: -$0.23 | +30.4% | $17.0KEst: $70.0K | -75.7% | 10-Q |
| May 7, 2025 | Q1 2025 | -$0.20Est: -$0.21 | +4.8% | $38.0KEst: $60.0K | -36.7% | 10-Q |
| Mar 19, 2025 | Q4 2024 | -$0.25Est: -$0.23 | -8.7% | $24.0KEst: $30.0K | -20.0% | 10-K |
| Nov 6, 2024 | Q3 2024 | -$0.24Est: -$0.22 | -9.1% | $29.0KEst: $80.0K | -63.7% | 10-Q |
| Aug 7, 2024 | Q2 2024 | -$0.25Est: -$0.26 | +3.8% | $24.0KEst: $80.0K | -70.0% | 10-Q |
| May 8, 2024 | Q1 2024 | -$0.25Est: -$0.27 | +7.4% | -Est: $60.0K | -100.0% | 10-Q |
| Mar 20, 2024 | Q4 2023 | -$0.25Est: -$0.26 | +3.8% | $41.0KEst: $50.0K | -18.0% | 10-K |
| Nov 8, 2023 | Q3 2023 | -$0.23Est: -$0.34 | +32.4% | $42.0KEst: $90.0K | -53.3% | — |
| Aug 9, 2023 | Q2 2023 | -$0.34Est: -$0.36 | +5.6% | $123.0KEst: $120.0K | +2.5% | 10-Q |
| May 10, 2023 | Q1 2023 | -$0.34Est: -$0.38 | +10.5% | $100.0KEst: $80.0K | +25.0% | 10-Q |